Dugel Pravin 4

What Happened
Pravin Dugel, Executive Chairman, President and CEO of Ocular Therapeutix (OCUL), reported a gift transfer of 394,696 shares on April 9, 2026. The transaction is reported as a gift (code G) at $0.00 per share, with no cash consideration — total reported value $0.

Key Details

• Transaction date: 2026-04-09; Form 4 filed: 2026-04-13 (timely — within two business days).
• Transaction type/code: Gift (G). Report shows both a disposition and corresponding acquisition entry reflecting transfer to spouse.
• Shares transferred: 394,696 shares. Price per share: $0.00 (gift). Reported value: $0.
• Shares owned after transaction: Not specified in the filing.
• Footnote: The filer states the shares were transferred to his spouse for no consideration.

Context

• A gift to a spouse is a personal/household transfer and does not necessarily reflect the insider’s view of the company’s stock; such transfers are common for estate planning or household ownership consolidation.
• This was not an open-market sale or purchase — no cash changed hands and no proceeds were reported.
• Filing appears timely; there is no indication of a late report.